MRI: morphology |
Normal posterior element signal,20 retropulsed bone fragments,9,12,14,17 additional benign VCFs18,19
|
Abnormal posterior element signal,9–19 epidural or paravertebral soft-tissue mass,9,10,12–15,17–19 expanded posterior vertebral contour,9,11,12,14,18,24 metastasis in other vertebrae9,14,18
|
MRI: signal and enhancement patterns |
Preserved normal marrow signal,9–12,14,15,17 regular margins,13,17,28 linear horizontal hypointense T1/T2 band,4,9,11,14,18 fluid sign,9,18,19,26 normal enhancement relative to adjacent vertebrae and at 3 mo12,13,15,28
|
Geographic replacement of normal marrow signal,11,12,14–18,24,28 irregular margins,13,17,28 increased enhancement relative to adjacent vertebrae and at 3 mo12,13,15,28
|
MRI: diffusion |
No restricted diffusion18,27,30,32–45
|
Increased restricted diffusion18,27,30,32–45
|
MRI: chemical shift |
Loss of SI on opposed-phase18,51–53
|
No change or slight loss of SI on opposed-phase,18,51–53 ratio of opposed-phase to in-phase SI > 0.8–1.018,51–53
|
CT |
Retropulsed bone,54,55 puzzle sign,10,54,55 sharp fracture lines,10,54,55 intravertebral vacuum phenomenenon55
|
Bone destruction,10,54,55 epidural or focal paravertebral soft tissue mass54,55
|
PET |
SUV 2 SDs below liver SUV57–60
|
SUV of >3–4.7 or 2 SDs above liver SUV57–60
|
SPECT |
Vertebral body and/or facet joint uptake63
|
Vertebral body with pedicle and/or spinous process uptake,63 marginal uptake in cold lesion63
|